Artelo Biosciences Inc.
13F holders, Q2 2024 (June 30)6holders −1
2new positions
3sold out
$1.39avg. 13F price*
At the end of Q2 2024, 6 institutions reported holding Artelo Biosciences Inc. in their 13F filings, down 1 from Q1 2024. 2 opened new positions and 3 sold out. The largest holders were Geode Capital Management, LLC ($28K), Tower Research Capital LLC (TRC) ($8K) and Citigroup Inc. ($64).
- Company
- Artelo Biosciences Inc.
- CUSIP
- 04301G508
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $99 |
| Exits | 3 | $223 |
All 13F filers, Q1 2024 → Q2 2024: 1,027 shares bought and 151 shares sold, net +876 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Geode Capital Management, LLC | 0.00% | No change | 19,808 | $28K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +19.6% | 5,823 | $8K |
| Citigroup Inc. | 0.00% | New | 46 | $64 |
| Bank of America Corp. | 0.00% | New | 26 | $35 |
| Morgan Stanley | 0.00% | No change | 20 | $27 |
| Rothschild Investment LLC | 0.00% | No change | 8 | $11 |
"% of holder's portfolio" is ARTELO BIOSCIENCES INC's weight in each manager's 13F, not the share of Artelo Biosciences Inc. the manager owns.